Shamburg News · 8-K filed Oct 6, 2026, 4:57 PM EDT

Nuo Therapeutics Closes $325,000 Second Funding Under Loan Agreement; Director Pittman Participates

AURX · Nuo Therapeutics, Inc.

  • Material agreement
  • Financing
  • Materiality: medium

On October 6, 2026, Nuo Therapeutics closed the $325,000 Second Funding under its Amended and Restated Loan and Security Agreement, following an Assignment, Joinder, and Amendment No. 1 that also enabled a $100,000 commitment assignment and three new lenders. The Company states it has received an aggregate $2,000,000 from Lenders under the Loan Agreement. Director and more than 10% holder Scott M. Pittman assumed $25,000 of the assigned commitment and received warrants for 4,500 Shares and 458 Shares of prepayment warrants, plus an interest warrant for up to 2,750 Shares.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 1.01, 2.03, 3.02, 9.01, accession 0001437749-26-032242.

Written from the filing by Shamburg Markets. Figures are as reported by the company.